Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 124292
Published online Nov 27, 2026. doi: 10.4240/wjgs.124292
Published online Nov 27, 2026. doi: 10.4240/wjgs.124292
Table 3 Comparison of surgical parameters between the two groups, n (%)/mean ± SD
| Parameters | Non-eradication group (n = 143) | Eradication group (n = 128) | t/χ2 | P value |
| Surgical approach | 0.056 | 0.813 | ||
| Laparoscopic | 98 (68.53) | 86 (67.19) | ||
| Open | 45 (31.47) | 42 (32.81) | ||
| Reconstruction type | 1.478 | 0.478 | ||
| B-I | 64 (44.76) | 48 (37.50) | ||
| B-II | 52 (36.36) | 52 (40.63) | ||
| R-Y | 27 (18.88) | 28 (21.88) | ||
| Number of lymph nodes harvested | 31.48 ± 6.52 | 32.58 ± 5.98 | 1.511 | 0.132 |
| Postoperative hospital stay (days) | 11.16 ± 3.24 | 10.52 ± 2.88 | 1.829 | 0.069 |
- Citation: Shi RC, Jin D, Su D, Yang XT, Wang X, Hao JF, Yang ZW. Impact of perioperative Helicobacter pylori eradication therapy on long-term survival after distal gastrectomy for gastric cancer. World J Gastrointest Surg 2026; 18(11): 124292
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/124292.htm
- DOI: https://dx.doi.org/10.4240/wjgs.124292